FIG. 5.
COX-2 derived prostaglandin F2α (PGF2α) mediates endothelial dysfunction in renal arteries of RHRs. Acetylcholine (100 μM)-stimulated release of PGF2α (A), 8-isoprostane (B), and 6-keto PGF1α (prostacyclin [PGI2]) (C) in control rats, RHRs, and RHRs treated with celecoxib or tempol. Contractions induced by PGF2α (D), 8-isoprostane (E), and PGI2 (F) in renal arteries of RHRs and control rats. (G) Effects of celecoxib and SC-560 on H2O2 (100 μM)-stimulated released of PGF2α in renal arteries. (H) Plasma concentration of PGF2α in control rats, RHRs, and RHRs treated with celecoxib or tempol. (I) Effects of celecoxib and S18886 on PGF2α-induced reduction of EDRs in renal arteries from control rats. Results are mean±SEM of four to eight experiments. *p<0.05 versus control (SD), #p<0.05 versus RHR.